2023
The role of routine biopsy of the background liver in the management of hepatocellular carcinoma
Lee S, Ahmed M, Taddei T, Jain D. The role of routine biopsy of the background liver in the management of hepatocellular carcinoma. Human Pathology 2023, 138: 18-23. PMID: 37236406, DOI: 10.1016/j.humpath.2023.05.009.Peer-Reviewed Original ResearchConceptsLiver biopsyEarly HCC stagesHepatocellular carcinoma managementLarge university hospitalSeparate biopsiesCirrhosis statusClinical characteristicsClinical suspicionMedian ageEarly diseasePathology databaseRoutine biopsyHCC stageBiopsy resultsHCC patientsParenchymal findingsUniversity HospitalBackground liverHepatocellular carcinomaNontumoral liverHCC biopsiesBiopsyPatientsCirrhosisLiverDiagnosis and classification of vascular liver disorders
González I, Jain D. Diagnosis and classification of vascular liver disorders. Diagnostic Histopathology 2023, 29: 36-51. DOI: 10.1016/j.mpdhp.2022.10.005.Peer-Reviewed Original ResearchLiver vasculatureVascular liver disordersUnderlying liver diseaseNoncirrhotic portal hypertensionAcute liver failureDual blood supplyDiverse clinical presentationsTerminal portal venulesKey histologicPortal hypertensionAtypical presentationLiver biopsyLiver failureClinical featuresClinical presentationHepatic arteryLiver diseaseUnclear diagnosisHepatic veinHistologic findingsPortal veinChallenging disorderLiver disordersBlood supplyHepatic sinusoids
2022
An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma
Madoff DC, Abi-Jaoudeh N, Braxton D, Goyal L, Jain D, Odisio BC, Salem R, Schattner M, Sheth R, Li D. An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma. The Oncologist 2022, 27: 884-891. PMID: 35925597, PMCID: PMC9526481, DOI: 10.1093/oncolo/oyac139.Peer-Reviewed Original ResearchConceptsIntrahepatic cholangiocarcinomaBiomarker testingMultidisciplinary teamImage-guided liver biopsyMetastatic intrahepatic cholangiocarcinomaEvidence-based guidelinesIntrahepatic biliary treeNext-generation sequencingActionable genetic alterationsTreatment landscapeLiver biopsyMedical oncologistsInterventional oncologistsPoor prognosisAggressive malignancyBiliary treeTissue acquisitionBiopsy methodImaging modalitiesDesmoplastic natureGenetic alterationsTissue collectionNeedle choicePrecision medicineCholangiocarcinomaAn Appraisal of Immunohistochemical Stain Use in Hepatic Metastasis Highlights the Effectiveness of the Individualized, Case-Based Approach: Analysis of Data From a Tertiary Care Medical Center.
Wang JD, Sebastian C, Walther Z, Suresh T, Lacy J, Zhang X, Jain D. An Appraisal of Immunohistochemical Stain Use in Hepatic Metastasis Highlights the Effectiveness of the Individualized, Case-Based Approach: Analysis of Data From a Tertiary Care Medical Center. Archives Of Pathology & Laboratory Medicine 2022, 147: 185-192. PMID: 35512224, DOI: 10.5858/arpa.2021-0457-oa.Peer-Reviewed Original ResearchConceptsLiver biopsyUnknown primaryIHC markersPrimary siteTrue carcinomaTertiary care medical centerAvailable clinicopathologic dataSquamous cell carcinomaClinicopathologic dataHepatic metastasesNonepithelial tumorsCell carcinomaInstitutional databaseClinical managementStain usePractice patternsNeuroendocrine neoplasmsImmunohistochemical markersMedical CenterMorphologic patternsIndividualized approachCarcinomaBiopsyMetastasisTumorsConsensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group
Lohse AW, Sebode M, Bhathal PS, Clouston AD, Dienes HP, Jain D, Gouw ASH, Guindi M, Kakar S, Kleiner DE, Krech T, Lackner C, Longerich T, Saxena R, Terracciano L, Washington K, Weidemann S, Hübscher SG, Tiniakos D. Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group. Liver International 2022, 42: 1058-1069. PMID: 35230735, DOI: 10.1111/liv.15217.Peer-Reviewed Original ResearchConceptsAutoimmune hepatitisChronic autoimmune hepatitisLobular hepatitisLymphoplasmacytic hepatitisInflammatory changesLiver diseaseHistological featuresHistological criteriaConsensus criteriaInternational consensus criteriaExpert liver pathologistsDelphi panel approachChronic presentationAcute presentationLiver biopsyHistological diagnosisHistopathological diagnosisLiver pathologistsLiver pathologyConsensus statementConsensus recommendationsHepatitisPathology groupDisease severityPeriportal region
2021
Thick Fibrous Septa on Liver Biopsy Specimens Predict the Development of Decompensation in Patients With Compensated Cirrhosis
Jain D, Sreenivasan P, Inayat I, Deng Y, Ciarleglio MM, Garcia-Tsao G. Thick Fibrous Septa on Liver Biopsy Specimens Predict the Development of Decompensation in Patients With Compensated Cirrhosis. American Journal Of Clinical Pathology 2021, 156: 802-809. PMID: 33940622, PMCID: PMC8512277, DOI: 10.1093/ajcp/aqab024.Peer-Reviewed Original ResearchConceptsDevelopment of decompensationThick fibrous septaSeptal widthCompensated cirrhosisClinical decompensationSeptal thicknessFibrous septaEnd-stage liver disease (MELD) scorePrimary end pointSignificant portal hypertensionLiver Disease scoreLiver biopsy specimenLiver biopsy specimensNodule sizeCirrhosis decompensationHistologic cirrhosisCompensated patientsPortal hypertensionIndependent predictorsLiver biopsyCommon etiologyWorse prognosisBiopsy specimenBiopsy specimensUnivariate analysisEvolution of the liver biopsy and its future
Jain D, Torres R, Celli R, Koelmel J, Charkoftaki G, Vasiliou V. Evolution of the liver biopsy and its future. Translational Gastroenterology And Hepatology 2021, 6: 20-20. PMID: 33824924, PMCID: PMC7829074, DOI: 10.21037/tgh.2020.04.01.Peer-Reviewed Original ResearchLiver biopsyLiver tissueClinical practicePost-transplant complicationsRoutine clinical practiceTissue content analysisCommon indicationLiver diseaseNon-invasive methodMultiphoton microscopyHistologic evaluationMedical disordersEffective treatmentNew therapiesBiopsyClinical diagnosisClinical researchTissue samplesVisualization of tissuesTissue sectionsPrognostic capabilityClinical workflowImproved clinical diagnosisTissueDiagnosis
2018
Subacute liver failure due to autochthonous hepatitis E virus infection in an elderly man in the United States
Landry M, Kamili S, Jain D. Subacute liver failure due to autochthonous hepatitis E virus infection in an elderly man in the United States. Human Pathology Reports 2018, 12: 68-70. DOI: 10.1016/j.ehpc.2018.02.007.Peer-Reviewed Original ResearchHepatitis E virus infectionE virus infectionLiver failureElderly menDifferential diagnosisVirus infectionToxic injuryAutochthonous hepatitis E virus infectionAutochthonous hepatitis EAcute hepatitis CAnti-HEV IgMHistologic differential diagnosisANA positivityPanlobular hepatitisSubsequent serologyCholestatic hepatitisHepatitis CHepatitis EBiliary obstructionLiver biopsyImmunocompetent individualsFatal outcomeGenotype 3Early diagnosisAppropriate managementTranslocation of a gut pathobiont drives autoimmunity in mice and humans
Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, Costa FRC, Tiniakou E, Greiling T, Ruff W, Barbieri A, Kriegel C, Mehta SS, Knight JR, Jain D, Goodman AL, Kriegel MA. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 2018, 359: 1156-1161. PMID: 29590047, PMCID: PMC5959731, DOI: 10.1126/science.aar7201.Peer-Reviewed Original ResearchConceptsGut pathobiontAutoimmune-prone miceMurine findingsIntramuscular vaccinePathogenic autoantibodiesLiver biopsyAutoimmune responseAutoimmune patientsAntibiotic treatmentT cellsImmune diseasesAutoimmunitySusceptible humansPathobiontsSystemic tissuesHuman hepatocytesAutoantibodiesMortalityMiceCocultureHepatocytesGenetic backgroundTissueBiopsyPatients
2015
Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma
Nguyen T, Phillips D, Jain D, Torbenson M, Wu TT, Yeh MM, Kakar S. Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma. Archives Of Pathology & Laboratory Medicine 2015, 139: 1028-34. PMID: 26230595, DOI: 10.5858/arpa.2014-0479-oa.Peer-Reviewed Original ResearchConceptsHep Par 1Polyclonal carcinoembryonic antigenArginase-1Hepatocellular carcinomaGlypican-3Carcinoembryonic antigenPAR-1Immunohistochemical markersSensitive markerHepatocellular differentiationLiver biopsyCarcinomaBest overall sensitivityHepatocellular markersLimited tissueAntigen 1Overall sensitivityDiagnosisCombined useReliable diagnosisPositive resultsMarkersLimited role
2012
Quantitative histological‐hemodynamic correlations in cirrhosis
Sethasine S, Jain D, Groszmann RJ, Garcia‐Tsao G. Quantitative histological‐hemodynamic correlations in cirrhosis. Hepatology 2012, 55: 1146-1153. PMID: 22109744, PMCID: PMC3721182, DOI: 10.1002/hep.24805.Peer-Reviewed Original ResearchConceptsSignificant portal hypertensionPortal hypertensionFibrosis areaLiver biopsyCirrhotic nodulesNodule sizeHVPG measurementPortal pressureIndependent predictorsSeptal thicknessFibrous septaBiopsyPathophysiological implicationsCirrhosisHVPGPatientsSemiquantitative analysisNodulesOnly parameterHypertensionNumber of nodules
2010
Hyperferritinemia and iron overload in type 1 Gaucher disease
Stein P, Yu H, Jain D, Mistry PK. Hyperferritinemia and iron overload in type 1 Gaucher disease. American Journal Of Hematology 2010, 85: 472-476. PMID: 20575041, PMCID: PMC2895498, DOI: 10.1002/ajh.21721.Peer-Reviewed Original ResearchConceptsEnzyme replacement therapyType 1 Gaucher's diseaseSystemic iron overloadIron overloadGaucher diseaseLiver biopsySerum ferritinReplacement therapyTransferrin saturationHFE genotypeHFE mutationsType 1 Gaucher diseaseSubset of patientsSeverity Score IndexCorrelation of ferritinClinical iron overloadSevere hyperferritinemiaDisease activityPrior splenectomyFerritin levelsClinical spectrumHFE genotypingLiver volumeIntact spleenHigh prevalence
2008
Colchicine-associated Ring Mitosis in Liver Biopsy and Their Clinical Implications
Kamath A, Mehal W, Jain D. Colchicine-associated Ring Mitosis in Liver Biopsy and Their Clinical Implications. Journal Of Clinical Gastroenterology 2008, 42: 1060-1062. PMID: 18391833, PMCID: PMC3730132, DOI: 10.1097/mcg.0b013e31803815b4.Peer-Reviewed Original ResearchConceptsChronic hepatitis CLiver biopsyHepatitis CColchicine toxicityMultiorgan failureLiver injuryHistopathologic manifestationsTissue injuryGastrointestinal tractMedical conditionsBiopsyClinical implicationsSalivary glandsInjuryAntimitotic activityMitosesColchicineToxicityTransfusionHistopathologicGoutYearsKidneyLiverTract
2007
Increased T-Cell Sinusoidal Lymphocytosis in Liver Biopsies in Patients With Chronic Hepatitis C and Mixed Cryoglobulinemia
Carmack S, Taddei T, Robert ME, Mistry P, Jain D. Increased T-Cell Sinusoidal Lymphocytosis in Liver Biopsies in Patients With Chronic Hepatitis C and Mixed Cryoglobulinemia. The American Journal Of Gastroenterology 2007, 103: ajg200850138. PMID: 17970837, DOI: 10.1111/j.1572-0241.2007.01603.x.Peer-Reviewed Original ResearchConceptsPresence of MCMixed cryoglobulinemiaLiver biopsySinusoidal lymphocytosisSinusoidal lymphocytesChronic hepatitis C patientsHepatitis C virus infectionKupffer cell countsMean fibrosis stageOngoing antigenic stimulationC virus infectionChronic hepatitis CChronic hepatitis C.Hepatitis C patientsRisk of lymphomaCD8-positive cellsNumber of CD68Low viral loadStage of fibrosisT-cell lymphocytesC patientsHepatitis CMC patientsHepatitis C.Lymphocyte count
2006
Gastric Siderosis
Marginean EC, Bennick M, Cyczk J, Robert ME, Jain D. Gastric Siderosis. The American Journal Of Surgical Pathology 2006, 30: 514-520. PMID: 16625099, DOI: 10.1097/00000478-200604000-00013.Peer-Reviewed Original ResearchConceptsOral iron medicationDiagnosis of hemochromatosisIron medicationGastric biopsiesIron depositionMild gastritisGlandular epitheliumPattern AActive Helicobacter pylori infectionStromal cellsPattern BDiffuse iron depositionIron pill gastritisPattern CSurgical pathology filesHelicobacter pylori infectionConsecutive gastric biopsiesMucosal inflammationLiver biopsyPathology filesClinical featuresMucosal hemorrhageGastric antralPylori infectionGastric inflammation
2005
Liver Biopsy
Sheela H, Seela S, Caldwell C, Boyer JL, Jain D. Liver Biopsy. Journal Of Clinical Gastroenterology 2005, 39: 603-610. PMID: 16000929, DOI: 10.1097/01.mcg.0000170742.59134.60.Peer-Reviewed Original ResearchConceptsLiver biopsyCertain clinical settingsAutoimmune hepatitisEssential diagnostic toolLiver diseasePercutaneous approachCommon disorderIntraoperative approachDisease prognosisTherapeutic strategiesBiopsySerologic diagnosisClinical settingGenetic disordersDiagnostic toolDiagnosisDisordersLaboratory testsIndicationsHepatitisContraindicationsLaparoscopicComplicationsPrognosisDisease
2004
Rapid Progression of Autoimmune Hepatitis in the Background of Primary Sclerosing Cholangitis
Hong-Curtis J, Yeh M, Jain D, Lee JH. Rapid Progression of Autoimmune Hepatitis in the Background of Primary Sclerosing Cholangitis. Journal Of Clinical Gastroenterology 2004, 38: 906-909. PMID: 15492611, DOI: 10.1097/00004836-200411000-00015.Peer-Reviewed Original ResearchConceptsPrimary sclerosing cholangitisAutoimmune hepatitisOverlap syndromeSclerosing cholangitisLiver diseaseHemolytic anemiaAIH/PSC overlap syndromePrompt recoveryDiagnosis of AIHPatient's prompt recoveryAutoimmune liver diseaseAutoimmune hemolytic anemiaProgressive liver failurePrimary biliary cirrhosisAcidophil bodiesAutoimmune cholangitisInterface hepatitisImmunosuppressive therapyBiliary cirrhosisLiver biopsyLiver failureLymphoplasmacytic infiltrateUlcerative colitisClinical symptomsLiver function